Objective To research the result of pretreatment with P2Y12 receptor inhibitors weighed against no pretreatment about efficacy and safety of treatment of non-ST elevation severe coronary symptoms (ACS). observational evaluation from a randomized managed trial, and three observational research) fulfilled the inclusion requirements. No research was recognized for ticagrelor or cangrelor, and analyses had been… Continue reading Objective To research the result of pretreatment with P2Y12 receptor inhibitors